Common Knee Surgery May Do More Harm Than Good: A Critical Analysis
The recent study published in the New England Journal of Medicine has sent shockwaves through the medical community, revealing a disturbing truth about a common knee surgery. The findings suggest that thousands of Americans who undergo arthroscopic knee surgery to trim degenerative cartilage tears may be making their problems worse rather than better. This is a significant revelation, as it challenges the long-standing belief in the effectiveness of this procedure.
What makes this study particularly intriguing is the fact that it followed patients for a decade, providing a comprehensive understanding of the long-term effects. The researchers compared patients who received the actual procedure, those who underwent a sham surgery (a skin incision), and those who received no treatment. The results were eye-opening.
The study found that the surgery provided little to no benefit and was associated with accelerated osteoarthritis and higher rates of reoperation. In other words, patients who underwent the procedure experienced more pain and were more likely to require a total knee replacement in the future. This is a stark contrast to the expectations of many patients and healthcare providers.
One of the study's authors, Teppo Järvinen, an orthopedist and head of the Finnish Centre for Evidence-Based Orthopaedics, expressed his disbelief at the findings. He stated, 'I don't know how I would defend this procedure at all.' Järvinen's sentiment highlights the profound impact of the study, as it challenges the very foundation of a widely practiced surgical intervention.
The study's implications are far-reaching, as they suggest that many patients may be suffering unnecessarily. The researchers chose patients who were most likely to benefit, yet even in this group, the surgery failed to provide significant relief. This raises questions about the criteria used to select patients for such procedures.
The study's findings are not isolated incidents. Evidence has been accumulating for over a decade, indicating that arthroscopic knee surgery to shave torn, degenerative cartilage does not offer significant advantages over physical therapy. In Finland, arthroscopic rates have dropped by 90%, and similar trends are observed in the U.S., although at a slower pace.
A study of commercial claims in the U.S. revealed a 4% annual decrease in meniscus surgeries between 2010 and 2020. This trend is further supported by traditional Medicare fee-for-service data, which shows a steady decline in procedure numbers. These figures suggest that the medical community is gradually recognizing the limitations of arthroscopic knee surgery.
However, the debate surrounding this procedure remains complex. Robert Brophy, director of the Orthopaedic Clinical Research Center at Washington University in St. Louis, acknowledges the growing evidence for judicious use of the surgery but also notes that many patients do benefit. This highlights the challenge of striking a balance between patient needs and potential risks.
The issue of treatment appropriateness is a complex one, as it often depends on the physician's perspective. Financial considerations may also play a role, as physician payments are determined by the Relative Value Scale Update Committee (RUC), a committee composed largely of specialists. This raises questions about the influence of financial incentives on treatment decisions.
Arthroscopic knee surgery, which typically takes 30 to 60 minutes in the operating room, carries a significant cost. Medicare allocates an average of $2,159 to $3,875 for the procedure, and patients pay 20% of the fee as coinsurance. Commercial insurers charge significantly more, and these costs do not include the fees of surgeons and anesthesiologists. The financial implications of this surgery are substantial.
The history of treating chronic knee pain is a fascinating one. Fifty years ago, the treatment for cartilage tears was to remove the entire piece of cartilage, considering it a vestigial tissue. Today, the first-line therapy is physical therapy and weight loss, with arthroscopic surgery as a secondary option. The menu of injections, including steroids and stem cell treatments, is also available, although their long-term benefits are still debated.
As orthopedists reevaluate their approach to meniscus tears, they are introducing a newer procedure: sewing the torn cartilage back into place. However, this method is typically reserved for patients under 50 with acute injuries and clean tears, leaving many questions unanswered.
In conclusion, the study's findings challenge the status quo and raise important questions about the future of knee surgery. It highlights the need for a more nuanced approach to treating degenerative knee conditions, considering both the potential risks and benefits. As the medical community continues to grapple with these findings, it is crucial to prioritize patient well-being and evidence-based practice.
